Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: A meta-analysis of 56 cases

Histopathology

Volumn 60, Issue 4, 2012, Pages 570-585

  Tan, Leonard H C ^a   Tan, Soo Y ^a   Tang, Tiffany ^b   Lim, Soon T ^b   Tan, Daryl ^a   Lim, Lay C ^a   Kam, Grace L S ^a   Loh, Tze P ^c   Tao, Miriam ^b   Koay, Evelyn S C ^d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Angioimmunoblastic T cell lymphoma; Hyperplastic germinal centres; Pattern; Secondary B lineage lymphoma; Survival

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; AGED; ANGIOIMMUNOBLASTIC T LYMPHOCYTE LYMPHOMA; ARTICLE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLONAL VARIATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE REARRANGEMENT; GERMINAL CENTER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; META ANALYSIS; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMINAL CENTER; HUMANS; HYPERPLASIA; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

HUMAN HERPESVIRUS 4;

EID: 84857366770     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04097.x     Document Type: Article

References (43)

1. Dogan A, Gaulard P, Jaffe E, Ralfkiaer E, Müller-Hermelink HK. Angioimmunoblastic T-cell lymphoma. In Swerdlow SH, Campo E, Harris NL et al. eds. World Health Organization classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon: IRAC, 2008; 309-311.
2. Swerdlow SH, Campo E, Harris NL et al. eds. World Health Organization classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon: IRAC, 2008.
3. Vose J, Armitage J, Weisenburger D et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. Clin. Oncol. 2000; 26; 4124-4130.
4. Lim ST, Hee SW, Quek R et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Eur. J. Haematol. 2008; 80; 55-60.
5. de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br. J. Haematol. 2010; 148; 673-689.
6. Iqbal J, Weisenburger DD, Greiner TC et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115; 1026-1036.
7. Mourad N, Mounier N, Briere J et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2008; 111; 4463-4470.
8. Lee SS, Rüdiger T, Odenwald T, Roth S, Starostik P, Müller-Hermelink HK. Angioimmunoblastic T-cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int. J. Cancer 2003; 103; 12-20.
9. Lome-Maldonado C, Canioni D, Hermine O et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?. Leukemia 2002; 16; 2134-2141.
10. Lee Y, Lee KW, Kim JH et al. Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma. Korean J. Intern. Med. 2008; 23; 30-36.
11. Niino D, Kawano R, Arakawa F, Sugita Y, Suefuji N, Ohshima K. No correlation between immunoglobulin heavy chain rearrangements and the prognosis of angioimmunoblastic T-cell lymphoma. Eur. J. Haematol. 2009; 83; 159-160.
12. Ree HJ, Kadin ME, Kikuchi M et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am. J. Surg. Pathol. 1998; 22; 643-655.
13. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Suzumiya J, Go JH. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum. Pathol. 1999; 30; 403-411.
14. Kojima M, Nakamura S, Itoh H et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: a clinicopathological and immunohistochemical study of 10 cases. APMIS 2001; 109; 699-706.
15. Attygalle A, Al-Jehani R, Diss TC et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99; 627-633.
16. Attygalle AD, Chuang SS, Diss TC, Du MQ, Isaacson PG, Dogan A. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007; 50; 498-508.
17. Attygalle AD, Kyriakou C, Dupuis J et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am. J. Surg. Pathol. 2007; 31; 1077-1088.
18. FH) cells. Blood 2007; 109; 4952-4963.
19. Piccaluga PP, Agostinelli C, Califano A et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007; 67; 10703-10710.
20. Tan LHC, Chiu LL, Koay ESC. Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO Criteria. Mol. Diagn. Ther. 2007; 11; 29-53.
21. Tan LHC. A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno-ontogenic principles. Pathology 2009; 41; 305-326.
22. McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn. Mol. Pathol. 1992; 1; 173-179.
23. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J. Clin. Pathol. 1992; 45; 770-775.
24. Jones D, Jorgensen JL, Shahsafaei A, Dorfman DM. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am. J. Surg. Pathol. 1998; 22; 956-964.
25. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics, 2nd edn. London: Prentice-Hall, 1994.
26. Huang Y, Moreau A, Dupuis J et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am. J. Surg. Pathol. 2009; 33; 682-690.
27. Qubaja M, Audouin J, Moulin JC et al. Nodal follicular helper T-cell lymphoma may present with different patterns. A case report. Hum. Pathol. 2009; 40; 264-269.
28. Warnke RA, Jones D, Hsi ED. Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. Am. J. Clin. Pathol. 2007; 127; 511-527.
29. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20; 313-318.
30. Ikonomou IM, Tierens A, Troen G et al. Peripheral T-cell lymphoma with involvement of the expanded mantle zone. Virchows Arch. 2006; 449; 78-87.
31. Su GH, Chen HM, Muthusamy N et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 1997; 16; 7118-7129.
32. Bartholdy B, duRoure C, Bordon A, Emslie D, Corcoran LM, Matthias P. The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. Proc. Natl Acad. Sci. USA 2006; 103; 11665-11670.
33. Garrett-Sinha LA, Su GH, Rao S et al. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 1999; 10; 399-408.
34. Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu YJ. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J. Exp. Med. 1997; 185; 563-571.
35. de Vinuesa CG, Cook MC, Ball J et al. Germinal centers without T cells. J. Exp. Med. 2000; 191; 485-494.
36. DeKoter RP, Geadah M, Khoosal S et al. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol. 2010; 185; 7374-7384.
37. Bagdi E, Krenacs L, Krenacs T, Miller K, Isaacson PG. Follicular dendritic cells in reactive and neoplastic lymphoid tissues: a reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. Appl. Immunohistochem. Mol. Morphol. 2001; 9; 117-124.
38. Schmidlin H, Diehl SA, Nagasawa M et al. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 2008; 112; 1804-1812.
39. Kashiwakuma D, Suto A, Hiramatsu Y et al. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses. J. Immunol. 2010; 185; 2730-2736.
40. Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008; 29; 127-137.
41. Marshall AJ, Niiro H, Yun TJ, Clark EA. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cγ pathways. Immunol. Rev. 2000; 176; 30-46.
42. Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood 2004; 103; 188-193.
43. Zhou Y, Attygalle AD, Chuang SS et al. Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. Br. J. Haematol. 2007; 138; 44-53.